PRAX
NASDAQ · Biotechnology
Praxis Precision Medicines I
$330.02
-3.26 (-0.98%)
Performance
1D
—
1W
—
1M
—
3M
+2.98%
6M
+79.74%
1Y
+758.98%
YTD
+15.23%
Open$331.00
Previous Close$333.28
Day High$341.75
Day Low$326.16
52W High$356.00
52W Low$35.18
Volume—
Avg Volume424.9K
Market Cap9.28B
P/E Ratio—
EPS$-13.45
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$296.27
Above
SMA 200
$133.67
Above
RSI (14)
61.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-94.1% upside
Current
$330.02
$330.02
Target
$19.45
$19.45
$15.93
$19.45 avg
$25.00
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.03M | 1.51B | 1.36B |
| Net Income | -278,552,680 | -397,237,584 | -445,831,143 |
| Profit Margin | -2,137.5% | -26.4% | -32.9% |
| EBITDA | -304,436,703 | -626,558,933 | -546,408,810 |
| Free Cash Flow | — | -309,826,002 | -348,261,984 |
| Rev Growth | — | +19.5% | +13.8% |
| Debt/Equity | — | 0.24 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |